European Society of Toxicology In Vitro > News > ATLA Launching 4 special issues on NAMs!
1 April 2021

ATLA Launching 4 special issues on NAMs!

The four special virtual issues are focusing on:

  • Biobanking – discuss the suitability of your MS with the VSC Editor Rita Seabra <rita@frame.org.uk>
  • In silico tools – discuss the suitability of your MS with the VSC Editor Judith Madden <J.C.Madden@ljmu.ac.uk>
  • Serum-free approaches – discuss the suitability of your MS with the VSC Editor Helena Kandarova <helena.kandarova@outlook.sk>
  • Educational resources – discuss thesuitability of your MS with the VSC Editor Esther Haugabrooks <EHaugabrooks@pcrm.org>

Articles will be made available online (subject to access rights) as soon as they are published.
• High visibility on the award-winning SAGE Journals platform, securing a wide international audience, including researchers, policymakers and educators.
• Prompt publishing and no submission or publication fees payable.

About the journal
ATLA is a peer-reviewed international journal that has been at the forefront of promoting and publishing on all aspects of the development, validation, implementation and use of animal alternatives, for almost 50 years. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo experiments that are still carried out (the Three Rs).

Related content

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

Silver Sponsor

Communication partners

Memorandum of Understanding